Rasd2 Modulates Prefronto-Striatal Phenotypes in Humans and 'Schizophrenia-Like Behaviors' in Mice

Neuropsychopharmacology

Volumn 41, Issue 3, 2016, Pages 916-927

  Vitucci, Daniela ^a,b   Di Giorgio, Annabella ^c   Napolitano, Francesco ^a,d   Pelosi, Barbara ^e   Blasi, Giuseppe ^f   Errico, Francesco ^a,d   Attrotto, Maria Teresa ^f   Gelao, Barbara ^f   Fazio, Leonardo ^f   Taurisano, Paolo ^f   Di Maio, Anna ^a   Marsili, Valentina ^a   Pasqualetti, Massimo ^e,g   Bertolino, Alessandro ^f,h   Usiello, Alessandro ^a,i  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF PISA   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^h PRED Hoffmann La Roche   (Switzerland)

ⁱ SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; MESSENGER RNA; PHENCYCLIDINE; PROTEIN; RASD2 PROTEIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN; RASD2 PROTEIN, HUMAN; RASD2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLD SIGNAL; BRAIN CORTEX; BRAIN FUNCTION; BRAIN SIZE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HABITUATION; HUMAN; HUMAN TISSUE; HYPERACTIVITY; IN VIVO STUDY; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PUTAMEN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SENSORY GATING; SOUND INTENSITY; STARTLE REFLEX; WORKING MEMORY; ADOLESCENT; ADULT; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; GTP-BINDING PROTEINS; HUMANS; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; RNA, MESSENGER; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84954027127     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.228     Document Type: Article

References (50)

1. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: Normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258.
2. Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J et al (2014). The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: Old fashioned, but still in vogue. Front Psychiatry 5: 47.
3. Consortium EP (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
4. Costa-Mattioli M, Monteggia LM (2013). mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat Neurosci 16: 1537-1543.
5. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW et al (2002). A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiatry 159: 803-812.
6. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 36: 131-137.
7. Errico F, Santini E, Migliarini S, Borgkvist A, Centonze D, Nasti V et al (2008). The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons. Mol Cell Neurosci 37: 335-345.
8. Falk JD, Vargiu P, Foye PE, Usui H, Perez J, Danielson PE et al (1999). Rhes: A striatal-specific Ras homolog related to Dexras1. J Neurosci Res 57: 782-788.
9. Gargiulo PA, Landa De Gargiulo AI (2014). Glutamate and modeling of schizophrenia symptoms: Review of our findings: 1990-2014. Pharmacol Rep 66: 343-352.
10. Ghiglieri V, Napolitano F, Pelosi B, Schepisi C, Migliarini S, Di Maio A et al (2015). Rhes influences striatal cAMP/PKAdependent signaling and synaptic plasticity in a gender-sensitive fashion. Sci Rep 5: 10933.
11. Goldman-Rakic PS (1995). Cellular basis of working memory. Neuron 14: 477-485.
12. Gottesmann C (2003). Inhibitory processes in the brain. Drug Discov Today 8: 1020-1021.
13. Harrison LM, Lahoste GJ (2013). The role of Rhes, Ras homolog enriched in striatum, in neurodegenerative processes. Exp Cell Res 319: 2310-2315.
14. Harrison LM, LaHoste GJ (2006). Rhes, the Ras homolog enriched in striatum, is reduced under conditions of dopamine supersensitivity. Neuroscience 137: 483-492.
15. Harrison LM, Lahoste GJ, Ruskin DN (2008). Ontogeny and dopaminergic regulation in brain of Ras homolog enriched in striatum (Rhes). Brain Res 1245: 16-25.
16. Harrison LM, Muller SH, Spano D (2013). Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum. Neuroscience 236: 21-30.
17. Javitt DC (2007). Glutamate and schizophrenia: Phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78: 69-108.
18. Jonas RK, Montojo CA, Bearden CE (2014). The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan. Biol Psychiatry 75: 351-360.
19. Jones CA, Watson DJ, Fone KC (2011). Animal models of schizophrenia. Br J Pharmacol 164: 1162-1194.
20. Kelly MP, Isiegas C, Cheung YF, Tokarczyk J, Yang X, Esposito MF et al (2007). Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKAdependent decreases in cAMP. Neuropsychopharmacology 32: 577-588.
21. Kulkarni J, Hayes E, Gavrilidis E (2012). Hormones and schizophrenia. Curr Opin Psychiatry 25: 89-95.
22. Kumari V (2011). Sex differences and hormonal influences in human sensorimotor gating: Implications for schizophrenia. Curr Top Behav Neurosci 8: 141-154.
23. Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM et al (2015). Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes. Neuron 85: 303-315.
24. Liu YL, Fann CS, Liu CM, Chen WJ, Wu JY, Hung SI et al (2008). RASD2, MYH9, and CACNG2 genes at chromosome 22q12 associated with the subgroup of schizophrenia with non-deficit in sustained attention and executive function. Biol Psychiatry 64: 789-796.
25. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology (Berl) 94: 507-514.
26. Manzano J, Morte B, Scanlan TS, Bernal J (2003). Differential effects of triiodothyronine and the thyroid hormone receptor betaspecific agonist GC-1 on thyroid hormone target genes in the b ain. Endocrinology 144: 5480-5487.
27. Martino D, Di Giorgio A, D'Ambrosio E, Popolizio T, Macerollo A, Livrea P et al (2011). Cortical gray matter changes in primary blepharospasm: A voxel-based morphometry study. Mov Disord 26: 1907-1912.
28. Napolitano F, Bonito-Oliva A, Federici M, Carta M, Errico F, Magara S et al (2010). Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. J Neurosci 30: 11043-11056.
29. Pascoli V, Valjent E, Corbille AG, Corvol JC, Tassin JP, Girault JA et al (2005). cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: Role of beta 1-adrenoceptors. Mol Pharmacol 68: 421-429.
30. Pasqualetti M, Ori M, Castagna M, Marazziti D, Cassano GB, Nardi I (1999). Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience 92: 601-611.
31. Potash JB, Zandi PP, Willour VL, Lan TH, Huo Y, Avramopoulos D et al (2003). Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder. Am J Psychiatry 160: 680-686.
32. Ralph RJ, Paulus MP, Fumagalli F, Caron MG, Geyer MA (2001). Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: Differential effects of D1 and D2 receptor antagonists. J Neurosci 21: 305-313.
33. Sciamanna G, Napolitano F, Pelosi B, Bonsi P, Vitucci D, Nuzzo T et al (2015). Rhes regulates dopamine D2 receptor transmission in striatal cholinergic interneurons. Neurobiol Dis 78: 146-161.
34. Seeman P (2014). Clozapine, a fast-off-D2 antipsychotic. ACS Chem Neurosci 5: 24-29.
35. Spano D, Branchi I, Rosica A, Pirro MT, Riccio A, Mithbaokar P et al (2004). Rhes is involved in striatal function. Mol Cell Biol 24: 5788-5796.
36. Subramaniam S, Mealer RG, Sixt KM, Barrow RK, Usiello A, Snyder SH (2010). Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9. J Biol Chem 285: 20428-20432.
37. Subramaniam S, Napolitano F, Mealer RG, Kim S, Errico F, Barrow R et al (2012). Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA-induced dyskinesia. Nat Neurosci 15: 191-193.
38. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M et al (2003). Diverse psychotomimetics act through a common signaling pathway. Science 302: 1412-1415.
39. Svensson TH (2000). Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs. Brain Res Brain Res Rev 31: 320-329.
40. Swerdlow NR, Geyer MA (1998). Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull 24: 285-301.
41. Tan HY, Nicodemus KK, Chen Q, Li Z, Brooke JK, Honea R et al (2008). Genetic variation in AKT1 is linked to dopamineassociated prefrontal cortical structure and function in humans. J Clin Invest 118: 2200-2208.
42. Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR (2007). Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull 33: 69-94.
43. Usiello A, Baik JH, Rouge-Pont F, Picetti R, Dierich A, LeMeur M et al (2000). Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408: 199-203.
44. Vallortigara J, Alfos S, Micheau J, Higueret P, Enderlin V (2008). T3 administration in adult hypothyroid mice modulates expression of proteins involved in striatal synaptic plasticity and improves motor behavior. Neurobiol Dis 31: 378-385.
45. Vallortigara J, Chassande O, Higueret P, Enderlin V (2009). Thyroid hormone receptor alpha plays an essential role in the normalisation of adult-onset hypothyroidism-related hypoexpression of synaptic plasticity target genes in striatum. J Neuroendocrinol 21: 49-56.
46. Vargiu P, De Abajo R, Garcia-Ranea JA, Valencia A, Santisteban P, Crespo P et al (2004). The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors. Oncogene 23: 559-568.
47. Vargiu P, Morte B, Manzano J, Perez J, de Abajo R, Gregor Sutcliffe J et al (2001). Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Brain Res Mol Brain Res 94: 1-8.
48. Vauquelin G, Bostoen S, Vanderheyden P, Seeman P (2012). Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism. Naunyn Schmiedebergs Arch Pharmacol 385: 337-372.
49. Wenthur CJ, Bennett MR, Lindsley CW (2014). Classics in chemical neuroscience: Fluoxetine (Prozac). ACS Chem Neurosci 5: 14-23.
50. Xu R, Hranilovic D, Fetsko LA, Bucan M, Wang Y (2002). Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry 7: 1075-1082.